Is it legal to buy semaglutide labeled “research use only”? FDA’s statements and warning letters

Is it legal to buy semaglutide labeled for research use only?

FDA’s statements in this index address sellers, not buyers: FDA states it has warned companies that sold unapproved semaglutide, tirzepatide, retatrutide, survodutide or mazdutide falsely labeled “for research purposes” or “not for human consumption” directly to consumers with dosing instructions (FDA page current as of October 1, 2026). As of Nov 15, 2026, 15 FDA warning letters in this index quote that kind of labeling, 13 of them naming semaglutide.

This page is not legal advice. It lists FDA’s statements and letters.

The table below also includes letters naming retatrutide, cagrilintide or another investigational GLP-1 ingredient (26 letters in all). 21 name retatrutide, which FDA states cannot be used in compounding under federal law.

FDA’s statements

FDA’s page does not date each paragraph; the date shown is the page’s “content current as of” date.

The letters

Later letters FDA listsLetter
Aug 24, 2026TXP Innovations LLC dba Tex PeptidesUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026Royal Peptides LLCUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026NuScience Peptides LLCUnapproved New Drugs/MisbrandedSemaglutide, Retatrutide, Survodutide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026Peptide Partners LLCUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026Peak Performance PeptidesUnapproved New Drugs/MisbrandedSemaglutide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Prime SciencesUnapproved New Drugs Sold Over the InternetSemaglutide, Tirzepatide, Retatrutide, Cagrilintide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Mile High Compounds LLCUnapproved New Drugs Sold Over the InternetSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Lovega LLC dba Pink Pony PeptidesUnapproved New Drugs Sold Over the InternetTirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Gram PeptidesUnapproved New Drugs Sold Over the InternetTirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026PekCura LabsUnapproved New Drugs Sold Over the InternetCagrilintideNone listed by FDA as of Nov 15, 2026fda.gov
Jan 20, 2026GenoGenix LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 8, 2025Darmerica, LLCCGMP/Active Pharmaceutical Ingredient (API)/Adulterated/MisbrandedRetatrutide, CagrilintideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 10, 2025motionpharmacy.comUnapproved New Drug/MisbrandedSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Amazing MedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025GenLabMedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025MedClub by Dr. JennUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025GLP-1 SolutionUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025ASN-LABSUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025EA WORKS Limited Liability Company dba Trust LabsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 26, 2025USApeptide.comUnapproved New Drugs/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024Prime Vitality, Inc. dba Prime PeptidesUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024SwisschemsUnapproved New Drugs/MisbrandedSemaglutide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024Xcel Research LLCUnapproved New Drugs/MisbrandedSemaglutide, Retatrutide, Cagrilintide, Survodutide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024Summit Research PeptidesUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, Retatrutide, Cagrilintide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 7, 2024US Chem LabsCGMP/Finished Pharmaceuticals/AdulteratedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 7, 2024Synthetix Inc. DBA Helix Chemical SupplyUnapproved New Drugs/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov

A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.

Common questions

Can retatrutide be compounded?

FDA states that retatrutide and cagrilintide cannot be used in compounding under federal law and are not components of FDA-approved drugs (FDA page content current as of October 1, 2026).

Which sellers of “research use only” GLP-1s got FDA warning letters?

15 letters in this index quote research-use or not-for-human-consumption labeling as of Nov 15, 2026. Each is in the table with the recipient, date and FDA subject line.

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.